Connect with us

News

Modern Observability Startup ‘Lightstep’ Joins 10KMedia as a Premier Client

gbafNews28

Lightstep, the modern Observability platform disrupting traditional monitoring solutions, today becomes a client of 10KMedia, a PR agency hyper-focused on DevOps. Other active clients include commercial Chaos Engineering solution Gremlin, founded by engineers from Amazon and Netflix; and rapid debugging startup Rookout, based out of Tel-Aviv, Israel.

Weve been interested in working with 10KMedia since we heard about the agency launching a few months ago, said David Klein, Head of Marketing at Lightstep. Adams experience with developers goes back to his days at DigitalOcean, and his subsequent work at companies like Datadog and Gremlin demonstrate his expertise in the DevOps space.

Adam LaGreca, founder of 10KMedia, was the PR Coordinator at DigitalOcean from 2013 – 2016, when it was one of the fastest growing startups in NYC and outpacing AWS in terms of new servers coming online. He went on to become the Senior Public Relations Manager for Datadog, where he played a key role in establishing the pre-IPO company as the market leader in cloud monitoring.

“Adam joined Datadog in 2016 as we were growing fast yet still under the radar, said Olivier Pomel, CEO and Co-Founder of Datadog. He helped us get the right level of media attention with poise and enthusiasm.

After Datadog (NASDAQ:DDOG), LaGreca became the Director of Communications at Gremlin, a startup founded by engineers from Amazon and Netflix pioneering the cutting-edge discipline of Chaos Engineering. Adam was key in helping us build a brand new category, said Kolton Andrus, Co-Founder and CEO of Gremlin. His ability to explain the impact of new technologies to existing business and the press has been invaluable. He is constantly looking for opportunities to help build awareness, while providing real value to everyone involved.

When 10KMedia launched in June, Gremlin immediately signed on as a client, followed by Rookout based in Tel-Aviv.

I am very picky about the clients that I take on, said LaGreca. Traditional PR agencies tend to have a lot of churn. I want to build meaningful, long-term relationships with startups that I believe will have a lasting impact. Lightstep has been on my radar since they launched in 2017. Its a great opportunity for me personally, to play a role in evangelizing a new way to observe and understand software.

About 10KMedia

10KMedia is a boutique PR agency hyper-focused on B2B DevOps. The agencys founder led communications for premier startups DigitalOcean and Datadog. Current clients include Gremlin, Rookout, and Lightstep. Operations are based in Dumbo, Brooklyn.

About LightStep

LightSteps mission is to deliver confidence at scale for those who develop, operate and rely on todays powerful software applications. Its products leverage distributed tracing technology “ initially developed by a LightStep co-founder at Google “ to offer best-of-breed observability to organizations adopting microservices or serverless at scale. LightStep is backed by Redpoint, Sequoia, Altimeter Capital, Cowboy Ventures and Harrison Metal and is headquartered in San Francisco, CA.

For 10KMedia

Adam LaGreca

[email protected]

News

IT Tech Packaging, Inc. Advances Additional Orders Negotiation with One of Its Top 5 Customers

gbafNews28

BAODING, China, Sept. 24, 2020 /PRNewswire/ — IT Tech Packaging, Inc. (NYSE American: ITP) ("IT Tech Packaging" or "the Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced that the Company is advancing negotiation with one of its top 5 customers, based in Shandong Province for orders of the paper products. The customer is currently ranked among the top 5 customers of the Company during the past couple of years.

Based on the negotiation, the Company and the customer will further cooperate on products supply and purchase in the next quarters and definitive new contracts are expected to be signed by the end of the year. Based on its increasing clients’ demand, the customer will continue to increase its purchase orders from the Company.

Mr. Zhenyong Liu, Chairman and Chief Executive Officer of IT Tech Packaging commented, "We are pleased with the negotiation with the customer for further partnership. As Chinese economy recovers from the COVID-19 epidemic with an amazing pace, our top clients such as companies focusing on printing and packaging are also receiving amount of orders and some even have backlog of orders, so they push forward the negotiations for raw materials and increase purchase volume of our products. We appreciate their confidence in our products as well as efficiency of delivery. We hope the stable partnership between us will continue contributing considerable revenue stream in the upcoming quarters."

About IT Tech Packaging, Inc.

Founded in 1996, IT Tech Packaging, Inc. is a leading manufacturer and distributor of diversified paper products in North China. Using recycled paper as its primary raw material (with the exception of its tissue paper products), ITP produces and distributes three categories of paper products: corrugating medium paper, offset printing paper and tissue paper products. With production based in Baoding and Xingtai in North China’s Hebei Province, ITP is located strategically close to the Beijing and Tianjin region, home to a growing base of industrial and manufacturing activities and one of the largest markets for paper products consumption in the country. ITP has been listed on the NYSE American since December 2009.

Safe Harbor Statements

This press release may contain forward-looking statements. These forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, including risks outlined in the Company’s public filings with the Securities and Exchange Commission, including the Company’s latest annual report on Form 10-K. All information provided in this press release speaks as of the date hereof. Except as otherwise required by law, the Company undertakes no obligation to update or revise its forward-looking statements.

For more information, please contact:

At the Company Email:
[email protected]
Tel: +86 0312 8698215

Investor Relations:
Janice Wang
+86-138-1176-8559
+1-908-510-2351
EverGreen Consulting Inc.
Email: [email protected]

Related Links :

http://www.itpackaging.cn/

Continue Reading

News

While 53% of US Physicians, 56% in the UK are Confident in Prescribing an Approved COVID-19 Vaccine, 42% in US Report their Patients are Vaccine Hesitant, According to Data from SurveyHealthcareGlobus

gbafNews28

With vaccine hesitancy threatening the ability for a potential COVID-19 vaccine to protect the public, new data show more than half of US and UK physicians surveyed feel confident in prescribing an FDA/EMA-approved vaccine. These physicians estimate that 42% of US patients are vaccine hesitant, the highest level in the survey. Respondents were Primary Care Physicians (PCPs) and their respective international counterparts from seven countries including the US, UK, France, Germany, Italy, Spain, and Canada. Findings were sourced by SurveyHealthcareGlobus (SHG), the global market leader of first-party healthcare data collection and custom survey solutions and part of the Apollo Intelligence, LLC family.

SHGs global COVID-19 vaccine hesitancy research found that on average physicians estimate 36% of their patients will be hesitant to receive a COVID-19 vaccine. UK physicians report the lowest levels of hesitancy, at 27%, while German physicians estimate 41% of their patients will be hesitant, rivaling the US, at 42%.

US physicians were the least confident in government policies about vaccine safety and vaccine rollout among those polled (33% and 26% respectively), with German physicians the most confident (54% and 51% respectively).

For decades global health entities have pushed to eradicate patient vaccine hesitancy for proven vaccines. Our data shows that physicians in the West are demonstrating hesitance themselves for COVID-19 vaccines in development, said Daniel S. Fitzgerald, CEO and president of Apollo Intelligence, parent firm to SHG. Their focus on the importance of education, awareness, and transparency in the vaccine development process provides helpful guidance for vaccine developers and international public health leaders.

Twenty-two percent of global physicians report that patients with co-morbidities will be the most reluctant to take a COVID-19 vaccine, with these sentiments highest in Spain (27%) and Canada (30%). Other demographics include the elderly, with 21% of global physicians reporting their potential hesitation. Patients with pre-existing conditions (19%), immune-compromised (16%), and disabled (13%), were also noted by global respondents.

In the US, physicians expect that 24% of African-American and Latino minorities will be leery to receive the vaccines.

Confidence in the efficacy (10%) and safety (8%) of the Russian Sputnik V vaccine reflects the lowest levels for the seven topics addressing governmental agency approvals. Worldwide, physicians think vaccine distribution should prioritize residents of long-term care facilities (46%) and people with underlying medical conditions (38%). One physician noted:

Patient education and myth busting in media is vital. Well need to ensure theres adequate supply from the start of the campaign, and adequate resource for practices to deliver vaccine program en masse. We will also need to ensure real-time communication of vaccination status across the healthcare system to enable opportunistic vaccination where unvaccinated. UK, General Practitioner

SHGs Global COVID-19 Vaccine Hesitancy Report included perceptions from n=484 Primary Care Physicians (PCPs)and their respective international counterpartsin the US (n=95), UK (n=43), France (n=89), Germany (n=71), Italy (n=57), Spain (n=52), and Canada (n=77), and was fielded between September 5-9, 2020. Respondents prescribe at least 5 vaccines per month. For the complete findings, please download the full report.

About SurveyHealthcareGlobus

SurveyHealthcareGlobus, an Apollo Intelligence brand, has been providing access to physicians, allied healthcare professionals, payers, decision makers, and key opinion leaders worldwide for more than 15 years. It provides project management, sample access and custom survey solutions to a variety of market research firms, management consulting firms, big data companies, and a variety of other users of healthcare data collection. For more information, visit www.surveyhealthcareglobus.com.

Jessica Florez

Director of Marketing for SHG at Apollo Intelligence

[email protected]

646-616-9140

Mary Kae Marinac

PR Representative for Apollo Intelligence

[email protected]

978-685-3136

Continue Reading

News

Lightyear Capital Announces the Formation of ProfitSolv

gbafNews28

Lightyear Capital LLC (“Lightyear”), a New York-based private equity firm focused on financial services, announced today that investment funds affiliated with Lightyear have established ProfitSolv (or the “Company”) to acquire integrated billing, payments, and software solutions for legal, accounting, and other professional services firms including consulting, architecture, and engineering firms. ProfitSolv has made three acquisitions to date:

  • Rocket Matter, a leading cloud-based legal billing, practice management, and payment processing software business;
  • TimeSolv, a provider of cloud-based software for legal billing and timekeeping; and
  • ImagineTime, a practice management and payments company serving accounting and other professional services firms.

Investment funds affiliated with Lightyear are the Companys lead investor, and Greater Sum Ventures (GSV) holds a significant minority stake. The Company will seek to execute strategic acquisitions that will help expand its footprint within the professional services software and payments solutions industry, a highly fragmented market with a large number of small providers. Lightyear estimates the total addressable market for these solutions is approximately $1.4 billion in the legal vertical alone.

Kelley Castell has been appointed Chief Executive Officer of ProfitSolv. Mr. Castell joins ProfitSolv after having served in a variety of senior leadership roles at fintech and payments companies including Bluefin Payment Systems, Oasis Outsourcing, and First Data. I am excited to be working with the experienced teams from Lightyear and GSV to build on ProfitSolvs strong customer- and product-oriented strategy, achieve strong organic growth, and expand the business through acquisitions, said Mr. Castell.

Our investment in ProfitSolv reflects our long-term investment thesis that embedding payment solutions in vertically integrated, sector-specific software will continue to gain market share from more traditional software providers, said Mark F. Vassallo, Managing Partner of Lightyear. We believe that solutions which integrate and automate billing, invoicing, and electronic payments will deliver stronger, more efficient receivables management, particularly since most small businesses still process paper checks.

Lightyears affiliated investment funds have successfully invested in embedded and vertically integrated payments companies, including realized investments in HigherOne, which serves higher education institutions, and Alegeus, which manages consumer-directed healthcare payments, and a current investment in Therapy Brands, which serves behavioral and mental health professionals. In addition, Lightyear has accumulated considerable expertise in building companies through mergers and acquisitions with over 90 acquisitions made through its affiliated funds portfolio companies since 2000.

About Lightyear Capital LLC

Founded in 2000, Lightyear is a financial services-focused private equity firm based in New York. Through its affiliated private equity funds, Lightyear makes primarily control investments in North America-based, middle-market companies associated with financial services, including asset management and wealth management, banks and brokerage, commercial and consumer finance, financial technology, healthcare financial services, insurance, and tech-enabled business services. Lightyear brings focus and discipline to its investment process, as well as operating, transaction and strategic management experience, along with significant contacts and resources beyond capital. For more information, please visit www.lycap.com.

About Greater Sum Ventures

Greater Sum Ventures (GSV) is an entrepreneurial growth equity firm that invests in lower-middle market tech-enabled business services companies. With entrepreneurial roots and proven operational and investing experience, GSV builds platforms of growing technology companies that revolutionize the industries they serve. Guided by a unique perspective and playbook, GSV adds exceptional value to its growing portfolio, which includes Community Brands, Inhabit IQ, Therapy Brands, Transit Technologies, and Government Brands, among others. The firm was established in 2015 by the founders and leadership team of Ministry Brands, which would become the 2017 Private Equity Deal of the Year. Headquartered in Knoxville, Tennessee, GSV provides access to capital and consulting services to startups all over the world. To learn more, visit GreaterSumVentures.com.

Elliot Sloane

ThroughCo Communications

[email protected]

917-291-0833

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gbafNews28 gbafNews28
News23 mins ago

IT Tech Packaging, Inc. Advances Additional Orders Negotiation with One of Its Top 5 Customers

BAODING, China, Sept. 24, 2020 /PRNewswire/ — IT Tech Packaging, Inc. (NYSE American: ITP) ("IT Tech Packaging" or "the Company"),...

gbafNews28 gbafNews28
News2 hours ago

Glucuronolactone Market Procurement Intelligence Report With COVID-19 Impact Analysis | Global Forecasts, 2020-2024 | SpendEdge

The Glucuronolactone market will register an incremental spend of about $86 million, growing at a CAGR of 4.53% during the...

gbafNews28 gbafNews28
News2 hours ago

Dexcom Signs Multi-Year Collaboration Agreement with the University of Virginia to Advance Type 1 and Type 2 Diabetes Research

DexCom, Inc. (NASDAQ:DXCM) today announced it has signed a five-year collaboration agreement with the University of Virginia to advance its...

gbafNews28 gbafNews28
News2 hours ago

Solomon D. Trujillo Appointed to Chairman of Encantos

Encantos, the award-winning entertainment-driven edtech company creating direct-to-learner family brands, announced today that Solomon (Sol) Trujillo has been appointed as...

gbafNews28 gbafNews28
News2 hours ago

Phunware Announces Upward Revision to Third Quarter Net Revenues Guidance

Phunware, Inc. (NASDAQ: PHUN) (the Company), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services...

gbafNews28 gbafNews28
News2 hours ago

Millendo Therapeutics Announces Initiation of First-in-Human Clinical Trial of MLE-301, a Selective NK3R Antagonist

Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases with significant...

gbafNews28 gbafNews28
News2 hours ago

Canadian Municipalities Join Forces With Operation Lifesaver to Raise Awareness About Rail-Crossing Safety

Every year, dozens of Canadians are killed or seriously injured in collisions at railway crossings. In fact, there were 174...

gbafNews28 gbafNews28
News2 hours ago

Jitsi and Mattermost Team Up for Joint Hackathon – “Thriving in a Remote Environment”

8×8, Inc. (NYSE: EGHT), a leading integrated cloud communications platform, today announced a joint hackathon hosted by Jitsi and Mattermost...

gbafNews28 gbafNews28
News2 hours ago

OSI Systems Receives $59 Million Contract to Provide Security Inspection Systems to Hamad International Airport

OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Security division was awarded a contract...

gbafNews28 gbafNews28
News2 hours ago

IDC Launches the Future of Industry Ecosystems: Built on the Platform and Sharing Economy

The tactical and strategic priority list for leadership, built on the premise of a steady rate of change, has changed...